Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

Market Cap	7.18B -34.6%
Revenue (ttm)	3.40B +6.1%
Net Income	392.31M +20.2%
EPS	0.86 +21.5%
Shares Out	454.07M
PE Ratio	18.30
Forward PE	16.20
Dividend	0.40 (2.53%)
Ex-Dividend Date	May 13, 2026

Volume	4,319,600
Open	15.56
Previous Close	15.08
Day's Range	15.03 - 16.10
52-Week Range	14.92 - 24.03
Beta	0.25
Analysts	Buy
Price Target	20.41 (+29.1%)
Earnings Date	Aug 24, 2026

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 2,803
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300119

Financial Performance

In 2025, SHE:300119's revenue was 3.40 billion, an increase of 10.70% compared to the previous year's 3.07 billion. Earnings were 400.51 million, an increase of 33.18%.

Analyst Summary

According to 5 analysts, the average rating for 300119 stock is "Buy." The 12-month stock price target is ¥20.41, which is an increase of 29.10% from the latest price.

Price Target

¥20.41

(29.10% upside)

Analyst Consensus: Buy